Selected article for: "detectable viraemia and non progressor status"

Author: Dyer, Wayne B; Zaunders, John J; Yuan, Fang Fang; Wang, Bin; Learmont, Jennifer C; Geczy, Andrew F; Saksena, Nitin K; McPhee, Dale A; Gorry, Paul R; Sullivan, John S
Title: Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection
  • Document date: 2008_12_11
  • ID: 0ddutmdd_2
    Snippet: Conclusion: Detectable viraemia at study entry was predictive of loss of LTNP status and/or disease progression in 6 of 8, and differentiated slow progressors from elite LTNP who retained potent virological control. Sustained immunological suppression of viraemia was independently associated with preserved p24 proliferative responses, regardless of the strength and breadth of the CTL response. A decline in this protective p24 response preceded or.....
    Document: Conclusion: Detectable viraemia at study entry was predictive of loss of LTNP status and/or disease progression in 6 of 8, and differentiated slow progressors from elite LTNP who retained potent virological control. Sustained immunological suppression of viraemia was independently associated with preserved p24 proliferative responses, regardless of the strength and breadth of the CTL response. A decline in this protective p24 response preceded or correlated with loss of non-progressor status and/or signs of disease progression.

    Search related documents:
    Co phrase search for related documents
    • breadth strength and CTL response breadth strength: 1
    • breadth strength and detectable viraemia: 1
    • breadth strength and disease progression: 1
    • breadth strength and immunological suppression: 1
    • breadth strength and LTNP status: 1
    • breadth strength and LTNP status loss: 1
    • breadth strength and non progressor status: 1
    • breadth strength and non progressor status loss: 1
    • breadth strength and potent virological control: 1
    • breadth strength and proliferative response: 1
    • breadth strength and study entry: 1
    • breadth strength and study entry detectable viraemia: 1
    • breadth strength and sustained viraemia immunological suppression: 1
    • breadth strength and viraemia immunological suppression: 1
    • CTL response and proliferative response: 1, 2
    • CTL response and study entry: 1
    • CTL response and study entry detectable viraemia: 1
    • CTL response and sustained viraemia immunological suppression: 1
    • CTL response and viraemia immunological suppression: 1